The amino acid transporter SLC7A5 drives progression of PI3K-mutant intestinal cancer models and enhances response to MAPK-targeted therapy
Owen J. Sansom(Cancer Research UK Scotland Institute), Andrew D. Campbell(Cancer Research UK Scotland Institute)
Cited by 0
Related Papers
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
|Cancer Cell|2019|441
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
|EMBO Molecular Medicine|2015|263
LKB1 Haploinsufficiency Cooperates With Kras to Promote Pancreatic Cancer Through Suppression of p21-Dependent Growth Arrest
|Gastroenterology|2010|161
Wnt ligands influence tumour initiation by controlling the number of intestinal stem cells
|Nature Communications|2018|118
Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
|Cell Death and Differentiation|2014|113